Effectiveness of Ribavirin and Corticosteroids for Severe Acute Respiratory Syndrome

American Journal of Medicine

Volumn 122, Issue 12, 2009, Pages

  Lau, Eric H Y ^a   Cowling, Benjamin J ^a   Muller, Matthew P ^b,c   Ho, Lai Ming ^a   Tsang, Thomas ^d   Lo, Su Vui ^e   Louie, Marie ^c   Leung, Gabriel M ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c Canadian Severe Acute Respiratory Syndrome Research Network   (Canada)

^d Department of Health   (Hong Kong)

^e HOSPITAL AUTHORITY   (Hong Kong)

Author keywords

Corticosteroids; Effectiveness; Propensity score; Ribavirin; Severe acute respiratory syndrome

Indexed keywords

CORTICOSTEROID; RIBAVIRIN;

ADULT; ARTICLE; CANADA; CORTICOSTEROID THERAPY; DRUG EFFICACY; FATALITY; FEMALE; HONG KONG; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEVERE ACUTE RESPIRATORY SYNDROME; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANTIVIRAL AGENTS; CANADA; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HONG KONG; HOSPITALIZATION; HUMANS; L-LACTATE DEHYDROGENASE; MIDDLE AGED; PROPENSITY SCORE; RESPIRATORY DISTRESS SYNDROME, ADULT; RETROSPECTIVE STUDIES; RIBAVIRIN; SEVERITY OF ILLNESS INDEX;

EID: 72049083215     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2009.07.018     Document Type: Article

References (55)

1. World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. http://www.who.int/csr/sars/country/table2004_04_21/en/index.html Accessed 19 June 2008
2. World Health Organization. Situation updates - SARS. www.who.int/csr/don/archive/disease/severe_acute_respiratory_syndrome/en/index.html Accessed June 19 2008
3. CHINAdaily. Civet cats found at restaurants again. http://www.chinadaily.com.cn/china/2007-02/14/content_808890.htm Accessed June 19, 2008
4. Wang M., Yan M., Xu H., et al. SARS-CoV infection in a restaurant from palm civet. Emerg Infect Dis 11 (2005) 1860-1865
5. Chu D.K., Poon L.L., Chan K.H., et al. Coronaviruses in bent-winged bats (Miniopterus spp.). J Gen Virol 87 Pt 9 (2006) 2461-2466
6. Li W., Shi Z., Yu M., et al. Bats are natural reservoirs of SARS-like coronaviruses. Science 310 (2005) 676-679
7. Crotty S., Maag D., Arnold J.J., et al. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nat Med 6 (2000) 1375-1379
8. Nicholls J.M., Poon L.L., Lee K.C., et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet 361 (2003) 1773-1778
9. Peiris J.S., Chu C.M., Cheng V.C., et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361 (2003) 1767-1772
10. Cyranoski D. Critics slam treatment for SARS as ineffective and perhaps dangerous. Nature 423 (2003) 4
11. Stockman L.J., Bellamy R., and Garner P. SARS: systematic review of treatment effects. PLoS Med 3 (2006) e343
12. Muller M.P., McGeer A., Straus S.E., et al. Clinical trials and novel pathogens: lessons learned from SARS. Emerg Infect Dis 10 (2004) 389-394
13. Rosenbaum P.R., and Rubin D.B. The central role of the propensity score in observational studies for causal effects. Biometrika 70 (1983) 41-55
14. Madaras-Kelly K.J., Remington R.E., Oliphant C.M., et al. Efficacy of oral beta-lactam versus non-beta-lactam treatment of uncomplicated cellulitis. Am J Med 121 (2008) 419-425
15. Mangano D.T., Tudor I.C., and Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 354 (2006) 353-365
16. Reeves M.J., Gargano J.W., Luo Z., et al. Effect of pretreatment with statins on ischemic stroke outcomes. Stroke 39 (2008) 1779-1785
17. Seshadri R., Feldman B.M., Ilowite N., et al. The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysis. Arthritis Rheum 59 (2008) 989-995
18. Shaya F.T., Blume S.W., Blanchette C.M., et al. Selective cyclooxygenase-2 inhibition and cardiovascular effects: an observational study of a Medicaid population. Arch Intern Med 165 (2005) 181-186
19. Leung G.M., Hedley A.J., Ho L.M., et al. The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Ann Intern Med 141 (2004) 662-673
20. Cowling B.J., Muller M.P., Wong I.O., et al. Clinical prognostic rules for severe acute respiratory syndrome in low- and high-resource settings. Arch Intern Med 166 (2006) 1505-1511
21. Muller M.P., Richardson S.E., McGeer A., et al. Early diagnosis of SARS: lessons from the Toronto SARS outbreak. Eur J Clin Microbiol Infect Dis 25 (2006) 230-237
22. Svoboda T., Henry B., Shulman L., et al. Public health measures to control the spread of the severe acute respiratory syndrome during the outbreak in Toronto. N Engl J Med 350 (2004) 2352-2361
23. Pocock S. Clinical Trials: A Practical Approach (1983), Wiley, Chichester
24. Hernandez A.V., Steyerberg E.W., and Habbema J.D. Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements. J Clin Epidemiol 57 (2004) 454-460
25. Peduzzi P., Concato J., Kemper E., et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49 (1996) 1373-1379
26. Imbens G.W. The role of the propensity score in estimating dose-response functions. Biometrika 87 (2000) 706-710
27. Qu Y., and Lipkovich I. Propensity score estimation with missing values using a multiple imputation missingness pattern (MIMP) approach. Stat Med 28 (2009) 1402-1414
28. Hayes J.R., and Groner J.I. Using multiple imputation and propensity scores to test the effect of car seats and seat belt usage on injury severity from trauma registry data. J Pediatr Surg 43 (2008) 924-927
29. Rutten-van Mölken M.P., van Nooten F.E., Lindemann M., et al. A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease. PharmacoEcon 25 (2007) 695-711
30. Hill J.L., Waldfogel J., Brooks-Gunn J., and Han W.J. Maternal employment and child development: a fresh look using newer methods. Dev Psychol 41 (2005) 833-850
31. Tu W., and Zhou X. A bootstrap confidence interval procedure for the treatment effect using propensity score subclassification. Health Serv Outcomes Res Methodol 3 (2003) 135-147
32. R Development Core Team. R: A Language and Environment for Statistical Computing. http://www.R-project.org Accessed June 19, 2008
33. Lau EHY, Hsiung CA, Cowling BJ, et al. A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan, China. Bull World Health Organ. In press.
34. Booth C.M., Matukas L.M., Tomlinson G.A., et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 289 (2003) 2801-2809
35. Sung J.J., Wu A., Joynt G.M., et al. Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak. Thorax 59 (2004) 414-420
36. Tsui P.T., Kwok M.L., Yuen H., and Lai S.T. Severe acute respiratory syndrome: clinical outcome and prognostic correlates. Emerg Infect Dis 9 (2003) 1064-1069
37. Muller M.P., Dresser L., Raboud J., et al. Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome. Pharmacotherapy 27 (2007) 494-503
38. Lee N., Hui D., Wu A., et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 348 (2003) 1986-1994
39. Poutanen S.M., Low D.E., Henry B., et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med 348 (2003) 1995-2005
40. Cheng V.C., Hung I.F., Tang B.S., et al. Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome. Clin Infect Dis 38 (2004) 467-475
41. Koren G., King S., Knowles S., and Phillips E. Ribavirin in the treatment of SARS: a new trick for an old drug?. CMAJ 168 (2003) 1289-1292
42. Wong C.K., Lam C.W., Wu A.K., et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 136 (2004) 95-103
43. Lee N., Allen Chan K.C., Hui D.S., et al. Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients. J Clin Virol 31 (2004) 304-309
44. Peiris J.S.M., Guan Y., Poon L.L.M., Cheng V.C.C., et al. Severe acute respiratory syndrome (SARS). In: Scheld W.M., Hooper D.C., and Hughes J.M. (Eds). Emerging Infections (2007), ASM Press, Washington
45. Peiris J.S., Yuen K.Y., Osterhaus A.D., and Stohr K. The severe acute respiratory syndrome. N Engl J Med 349 (2003) 2431-2441
46. Peter J.V., John P., Graham P.L., et al. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ 336 (2008) 1006-1009
47. Lew T.W., Kwek T.K., Tai D., et al. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA 290 (2003) 374-380
48. Hong N., and Du X.K. Avascular necrosis of bone in severe acute respiratory syndrome. Clin Radiol 59 (2004) 602-608
49. Lau E.M., Chan F.W., Hui D.S., et al. Reduced bone mineral density in male Severe Acute Respiratory Syndrome (SARS) patients in Hong Kong. Bone 37 (2005) 420-424
50. Auyeung T.W., Lee J.S., Lai W.K., et al. The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study. J Infect 51 (2005) 98-102
51. Wang J.T., Sheng W.H., Fang C.T., et al. Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerg Infect Dis 10 (2004) 818-824
52. Chan K.S., Lai S.T., Chu C.M., et al. Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study. Hong Kong Med J 9 (2003) 399-406
53. Jia W., and Gao W. Is traditional Chinese medicine useful in the treatment of SARS?. Phytother Res 17 (2003) 840-841
54. Donders A.R., van der Heijden G.J., Stijnen T., and Moons K.G. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol 59 (2006) 1087-1091
55. World Health Organization. Case Definitions for Surveillance of Severe Acute Respiratory Syndrome (SARS). http://www.who.int/csr/sars/casedefinition/en/ Accessed June 19, 2008